ADRENOCORTICAL FUNCTION IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS TREATED WITH LOVASTATIN (MEVINOLIN)

被引：22
|
作者：
FOJO, SS
HOEGG, JM
LACKNER, KJ
ANCHORS, JM
BAILEY, KR
BREWER, HB
机构：
来源：
HORMONE AND METABOLIC RESEARCH | 1987年 / 19卷 / 12期
关键词：
D O I：
10.1055/s-2007-1011900
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：648 / 652
页数：5
相关论文
共 50 条
  • [1] TESTICULAR FUNCTION IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS TREATED WITH LOVASTATIN (MEVINOLIN) OR NEOMYCIN
    FARNSWORTH, WH
    HOEG, JM
    MAHER, M
    BRITTAIN, EH
    SHERINS, RJ
    BREWER, HB
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03): : 546 - 550
  • [2] HYPERCHOLESTEROLEMIC (TYPE-II HYPERLIPOPROTEINEMIC) ARTHRITIS
    RIMON, D
    COHEN, L
    JOURNAL OF RHEUMATOLOGY, 1989, 16 (05) : 703 - 705
  • [3] INCREASED LYSOLECITHIN ACYLTRANSFERASE ACTIVITY IN THE PLASMA OF TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    SUBBAIAH, PV
    OGILVIE, JT
    LIPIDS, 1984, 19 (02) : 80 - 84
  • [4] LIPID PEROXIDE LEVELS IN TYPE-II HYPERLIPOPROTEINEMIC SUBJECTS
    KAMEDATAKEMURA, K
    CORDER, CN
    LEE, DM
    ARTERY, 1993, 20 (04) : 189 - 200
  • [5] EFFECT OF LOVASTATIN ON HEMORHEOLOGY IN TYPE-II HYPERLIPOPROTEINEMIA
    KOPPENSTEINER, R
    MINAR, E
    EHRINGER, H
    ATHEROSCLEROSIS, 1990, 83 (01) : 53 - 58
  • [6] CHANGES IN LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES INDUCED BY ACIPIMOX IN TYPE-IV AND TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    SOMMARIVA, D
    POGLIAGHI, I
    BONFIGLIOLI, D
    CABRINI, E
    TIRRITO, M
    LAVEZZARI, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 37 (02): : 363 - 368
  • [7] INCREASED PLATELET SENSITIVITY AND THROMBOXANE-B2 FORMATION IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    TREMOLI, E
    MADERNA, P
    COLLI, S
    MORAZZONI, G
    SIRTORI, M
    SIRTORI, CR
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (05) : 329 - 333
  • [8] EFFECTIVENESS OF MEVINOLIN ON PLASMA-LIPOPROTEIN CONCENTRATIONS IN TYPE-II HYPERLIPOPROTEINEMIA
    HOEG, JM
    MAHER, MB
    ZECH, LA
    BAILEY, KR
    GREGG, RE
    LACKNER, KJ
    FOJO, SS
    ANCHORS, MA
    BOJANOVSKI, M
    SPRECHER, DL
    BREWER, HB
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (11): : 933 - 939
  • [9] LONG-TERM EFFECTS OF FENOFIBRATE ON SERUM-LIPIDS AND ON LIPOPROTEIN CHOLESTEROL IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS
    SOMMARIVA, D
    BONFIGLIOLI, D
    POGLIAGHI, I
    CABRINI, E
    FASOLI, A
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1984, 16 (08): : 809 - 820
  • [10] DECREASE IN LDL AND INCREASE IN HDL CONCENTRATIONS IN TYPE-II HYPERLIPOPROTEINEMIC PATIENTS ON LOW-DOSE COMBINATION THERAPY OF CHOLESTYRAMINE AND COMPLAMIN
    FEARS, R
    FERRES, H
    HAACKE, H
    MADER, C
    PARWARESCH, MR
    ATHEROSCLEROSIS, 1988, 69 (2-3) : 97 - 101
12345